Ängelholm, Sweden

Björn Weström

This inventor holds 1 USPTO granted patent. Top assignee: Anara Ab. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Björn Weström. Retrieved from https://idiyas.com/inventor/bjorn-westrom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Björn Weström

Introduction

Björn Weström is a notable inventor based in Ängelholm, Sweden. He has made significant contributions to the field of gastrointestinal health through his innovative patent. His work focuses on methods to enhance the maturation of the gastrointestinal tract, particularly the small intestine.

Latest Patents

Weström holds a patent titled "Maturation of gastrointestinal tract." This invention provides a method to induce maturation of an immature GI-tract. The method involves administering a mixture of enzymes that possess pancreatic activity to the immature GI-tract. Additionally, the invention includes analyzing the maturation process to monitor its progress. The patent also outlines various uses and kits designed to facilitate GI-tract maturation. He has 1 patent to his name.

Career Highlights

Björn Weström has established himself as a key figure in his field. His innovative approach to gastrointestinal health has garnered attention and recognition. He is associated with Anara AB, where he continues to develop and refine his ideas.

Collaborations

Weström collaborates with esteemed colleagues such as Stefan Pierzynowski and Olena Prykhod'ko. Their combined expertise contributes to the advancement of research in gastrointestinal maturation.

Conclusion

Björn Weström's contributions to the field of gastrointestinal health through his innovative patent demonstrate his commitment to improving medical science. His work has the potential to significantly impact the treatment of gastrointestinal issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…